piroxantrone has been researched along with Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guziec, FS; Guziec, LJ; Hasinoff, BB; Liang, H; Marshall, K; Wu, X; Yalowich, JC | 1 |
| Balis, FM; Berg, SL; Cowan, KH; Denicoff, AM; Hillig, M; O'Shaughnessy, JA; Poplack, DG; Savarese, DM | 1 |
| Baker, SP; Balis, FM; Berg, SL; Chow, C; Denicoff, AM; Hillig, M; O'Shaughnessy, JA; Otterson, GA; Poplack, DG; Savarese, DM | 1 |
| Fukuda, H; Kunitoh, H; Saijo, N; Sekine, I | 1 |
| Diasio, RB; Stagg, MP | 1 |
| Ames, MM; Collins, JM; Loprinzi, CL; Moertel, CG; Richardson, RL; Rubin, J; van Haelst-Pisani, C | 1 |
| Clarke, BV; Donehower, RC; Ettinger, DS; Grochow, LB; Hantel, A; McGuire, WP; Noe, DA; Rowinsky, EK; Vance, E | 1 |
2 review(s) available for piroxantrone and Neoplasms
| Article | Year |
|---|---|
Cancer chemotherapy in the elderly.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Anthraquinones; Antineoplastic Agents; Breast Neoplasms; Busulfan; Daunorubicin; Doxorubicin; Etoposide; Female; Fluorouracil; Heart; Hematologic Neoplasms; Humans; Lung; Male; Middle Aged; Neoplasms; Pyrazoles | 1998 |
Novel chemotherapeutic agents in early clinical development.
Topics: Adenine; Alkaloids; Anthraquinones; Antineoplastic Agents; Biphenyl Compounds; Camptothecin; Humans; Imides; Irinotecan; Isoquinolines; Naphthalimides; Neoplasms; Organophosphonates; Paclitaxel; Pyrazoles; Quinazolines; Sulfonylurea Compounds; Terpenes; Trimetrexate | 1990 |
4 trial(s) available for piroxantrone and Neoplasms
| Article | Year |
|---|---|
Pharmacokinetics of piroxantrone in a phase I trial of piroxantrone and granulocyte-colony stimulating factor.
Topics: Adult; Anthraquinones; Antineoplastic Agents; Granulocyte Colony-Stimulating Factor; Humans; Neoplasms; Pyrazoles | 1993 |
Phase I study of high-dose piroxantrone with granulocyte colony-stimulating factor.
Topics: Adult; Aged; Anthraquinones; Antineoplastic Agents; Bone Marrow Diseases; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Neoplasms; Pyrazoles | 1993 |
Novel chemotherapeutic agents in early clinical development.
Topics: Adenine; Alkaloids; Anthraquinones; Antineoplastic Agents; Biphenyl Compounds; Camptothecin; Humans; Imides; Irinotecan; Isoquinolines; Naphthalimides; Neoplasms; Organophosphonates; Paclitaxel; Pyrazoles; Quinazolines; Sulfonylurea Compounds; Terpenes; Trimetrexate | 1990 |
Phase I and clinical pharmacological evaluation of pirozantrone hydrochloride (oxantrazole).
Topics: Adult; Aged; Anthraquinones; Child; Clinical Trials as Topic; Drug Evaluation; Electrocardiography, Ambulatory; Erythrocyte Count; Female; Heart; Humans; Leukocyte Count; Middle Aged; Neoplasms; Pyrazoles | 1990 |
2 other study(ies) available for piroxantrone and Neoplasms
| Article | Year |
|---|---|
The structure-based design, synthesis and biological evaluation of DNA-binding bisintercalating bisanthrapyrazole anticancer compounds.
Topics: Anthracyclines; Antigens, Neoplasm; Antineoplastic Agents; Cell Line; Cell Survival; DNA; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Design; Enzyme Inhibitors; Humans; Models, Molecular; Molecular Structure; Neoplasms; Nucleic Acid Denaturation; Plasmids; Protein Binding; Quantitative Structure-Activity Relationship; Temperature; Topoisomerase II Inhibitors | 2008 |
Phase I study and pharmacodynamics of piroxantrone (NSC 349174), a new anthrapyrazole.
Topics: Adult; Aged; Anthraquinones; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Female; Heart; Humans; Leukopenia; Male; Middle Aged; Neoplasms; Pyrazoles | 1990 |